Cabazitaxel: a novel drug for hormone-refractory prostate cancer.

MLA

Malhotra, Manav, et al. “Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer.” Mini Reviews in Medicinal Chemistry, vol. 13, no. 6, May 2013, pp. 915–20. EBSCOhost, https://doi.org/10.2174/1389557511313060011.

APA

Malhotra, M., Dhingra, R., Sharma, T., Deep, A., Narasimhan, B., Phogat, P., & Sharma, P. C. (2013). Cabazitaxel: a novel drug for hormone-refractory prostate cancer. Mini Reviews in Medicinal Chemistry, 13(6), 915–920. https://doi.org/10.2174/1389557511313060011

Chicago

Malhotra, Manav, Richa Dhingra, Tina Sharma, Aakash Deep, Balasubramanian Narasimhan, Priyanka Phogat, and Prabodh Chander Sharma. 2013. “Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer.” Mini Reviews in Medicinal Chemistry 13 (6): 915–20. doi:10.2174/1389557511313060011.